V710
Biological
Merck Sharp & Dohme Corporation
Total Payments
$75,000
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $75,000 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $75,000 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Study re immunization in BALB-C and KO mice using Merck Staph vaccine antigens 2451, 1789 and 1173 | Merck Sharp & Dohme Corporation | $75,000 | 0 |
Top Doctors Receiving Payments for V710
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Chicago, IL | $75,000 | 2 |
Ad
Manufacturing Companies
- Merck Sharp & Dohme Corporation $75,000
Product Information
- Type Biological
- Total Payments $75,000
- Total Doctors 0
- Transactions 2
About V710
V710 is a biological associated with $75,000 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2017 to 2017. In 2017, $75,000 was paid across 2 transactions to 0 doctors.
The most common payment nature for V710 is "Unspecified" ($75,000, 100.0% of total).
V710 is associated with 1 research study, including "Study re immunization in BALB-C and KO mice using Merck Staph vaccine antigens 2451, 1789 and 1173" ($75,000).